- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00624598
The Short-Term Effect of a Technology Driven Weight Control (SMART) Program for Obese Adults (WCPC)
September 15, 2008 updated by: Colorado Center for Chronic Care Innovations, Inc.
Phase I Study of Integrating RMR Technology and Email Counseling in a PCP Office.
The purpose of this study is to evaluate the short-term effect of a technology based weight reduction program for obese (BMI > 30 kg/m2) adults in a primary care office.
Study Overview
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Westminster, Colorado, United States, 80031
- Westmed Family Healthcare
-
Westminster, Colorado, United States, 80031
- Westminster Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participant between the ages of 18-65 years.
- Participant with a BMI (Body Mass Index > 30.0 kg/m2)
- Have access and use email a minimum of 2-days per week.
Exclusion Criteria:
- Participant is not pregnant or lactating: Weight loss is not recommended for pregnant women and extra energy requirements are essential for fetal development (Butte, Wong, Treuth, Ellis, & O'Brian Smith, 2004; Durnin, 1991).
- Participant is not currently participating in any structured/self-help weight loss program. The elimination of individuals actively participating in a current weight loss program will reduce the potential of a carry-over effect from these weight loss modalities (Fife-Shaw, 2006).
- Participant has not attempted weight loss in the past 3 months. Same as number two.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SMART Group
The experimental group will have a nutrition program based solely on measured resting metabolic rate.
The nutrition plan will be a specific calorie level that will promote a 1-2.5 lb per week weight reduction.
No experimental participants' nutrition plan will be below 1200 Kcal/day for women or 1600 Kcal/day for men.
Second, the experimental group will receive a downloadable copy of a computerized nutrition software program (BalanceLog: Microlife USA, Inc. Golden, CO) that functions s on a Windows 2000-XP or Palm operating system.
|
Use of measured resting metabolic rate from indirect calorimetry for personalized diet program and use of a computer application for journalizing food and exercise.
|
Active Comparator: Usual Care
Standard 1200 kcal/day diet (women) 1600 kcal/day diet (men) using a sample 3-day menu program.
The diet will be follow current government based recommendations for carbohydrates (i.e.
55%), fat (30%), and protein (15%).
Study participants will receive a standard paper-based food and exercise journal
|
Use of measured resting metabolic rate from indirect calorimetry for personalized diet program and use of a computer application for journalizing food and exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Individuals receiving a technology-based weight reduction program will not have a significant increase in psychosocial constructs (i.e. weight self-efficacy, perceived behavioral control, attitude) compared to control group.
Time Frame: 10 weeks
|
10 weeks
|
Individuals receiving a technology-based weight reduction program will not improve eating behaviors (i.e. dietary cognitive restraint, emotional eating, uncontrolled eating) compared to control group.
Time Frame: 10 weeks
|
10 weeks
|
Individuals receiving a technology-based weight reduction program will not lose significantly more weight compared to control group.
Time Frame: 10 weeks
|
10 weeks
|
Individuals receiving a technology-based weight reduction program will not significantly improve systolic and diastolic blood pressure compared to control group(controlled for Bp medications).
Time Frame: 10 Weeks
|
10 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Individuals receiving a technology-based weight reduction program will not significantly improve weight quality of life compared to control group.
Time Frame: 10 weeks
|
10 weeks
|
There is no relationship between psychosocial values (i.e. weight self-efficacy, weight perceived behavioral control, weight attitude) and eating behaviors (i.e. dietary cognitive restraint, uncontrolled eating, and emotional eating).
Time Frame: 10 Weeks
|
10 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
August 1, 2008
Study Registration Dates
First Submitted
February 19, 2008
First Submitted That Met QC Criteria
February 26, 2008
First Posted (Estimate)
February 27, 2008
Study Record Updates
Last Update Posted (Estimate)
September 17, 2008
Last Update Submitted That Met QC Criteria
September 15, 2008
Last Verified
September 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C41 # 001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on SMART
-
Inje UniversityCompletedBRONCHIAL ASTHMAKorea, Republic of
-
Medical University of South CarolinaBoston Scientific CorporationRecruitingSubcutaneous ICD | Myopotential InterferenceUnited States
-
Massachusetts General HospitalElizabeth Dole FoundationCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterRecruitingPost Traumatic Stress DisorderUnited States
-
Lawson Health Research InstituteNot yet recruitingPTSD | Post-traumatic Stress DisorderCanada
-
NYU Langone HealthCompleted
-
Inje UniversityUnknownBOWEL PREPARATION (BOWEL CLEANSING)Korea, Republic of
-
Ariel UniversityCompletedAutism Spectrum DisorderIsrael